Select Justice
Expertise
Giving Back
About
Blog

Bayer Faces Setback with Five Consecutive Losses in Roundup Trials

Author
Josef Rappaport, DPT, Physical Therapist
January 7, 2024

Bayer, a global pharmaceutical and agrochemical company, has recently experienced a series of legal setbacks with five consecutive losses in lawsuits related to its widely used herbicide, Roundup. The active ingredient in Roundup, glyphosate, has been at the center of controversy due to allegations linking it to cancer. These legal defeats not only pose a significant financial threat to Bayer but also raise concerns about the safety of one of the world's most popular herbicides.

Free Case Evaluation

If you or a loved one were harmed by using Roundup Weedkiller you could be entitled to compensation.

line

 

Background

Year Name State Award Amount
2023 Durnell Missouri $1,250,000
2023 Caranci Pennsylvania $175,000,000
2023 Dennis California $332,000,000
2023 Anderson, etc. Missouri $1,561,100,000
2023 Martel Pennsylvania $3,462,500

Roundup, originally developed by Monsanto, became a staple in agriculture due to its effectiveness in killing weeds. However, concerns about the safety of glyphosate, the primary ingredient in Roundup, gained traction in recent years. The World Health Organization's International Agency for Research on Cancer (IARC) classified glyphosate as a probable human carcinogen in 2015, fueling a wave of lawsuits against Bayer, which acquired Monsanto in 2018.

The Legal Battles

Bayer has faced a slew of lawsuits from individuals claiming that exposure to Roundup caused them to develop non-Hodgkin lymphoma and other forms of cancer. The first loss came in 2018 when a California jury awarded $289 million to a groundskeeper who argued that Roundup exposure caused his terminal cancer. Subsequent cases resulted in substantial payouts, with Bayer struggling to defend its product's safety.

Recent Losses

The five consecutive losses represent a significant blow to Bayer's reputation and financial standing. In three separate trials in 2023, juries sided with plaintiffs, awarding substantial damages. The most recent losses underscore the increasing legal challenges and potential liabilities Bayer faces regarding Roundup.

Implications for Bayer

The legal defeats have led to a sharp decline in Bayer's stock value and a surge in shareholder concerns. The company is now grappling with the financial fallout, as the cumulative damages awarded to plaintiffs in the recent trials amount to billions of dollars. Moreover, these losses could prompt additional lawsuits, creating a domino effect that further damages Bayer's standing in the industry.

Regulatory Scrutiny

The legal battles surrounding Roundup have also attracted regulatory attention. Several countries and municipalities have either restricted or banned the use of glyphosate-based herbicides. Regulatory scrutiny and growing public awareness of the potential health risks associated with glyphosate may pose challenges for Bayer in maintaining Roundup's market share.

Bayer's Response

In response to the legal setbacks, Bayer has reiterated its confidence in the safety of Roundup and the regulatory approvals it has received over the years. The company plans to appeal the recent verdicts while maintaining that the scientific evidence supports the safety of glyphosate when used as directed.

Conclusion

Bayer's five consecutive losses in Roundup trials mark a significant turning point for the company. The legal challenges, coupled with the financial repercussions and regulatory scrutiny, raise questions about the future of Roundup and its impact on Bayer's overall business. As the legal battles continue, the outcomes will shape the narrative surrounding the safety of glyphosate and influence the broader landscape of herbicide use in agriculture.

More verdicts like these are expected to come in the near future. If you have not yet filed your claim, now is the time to do it.

Free Case Evaluation

If you or a loved one were harmed by using Roundup Weedkiller you could be entitled to compensation.

line

Related Articles

January 8, 2024
Bayer Faces Setback with Five Consecutive Losses in Roundup Trials

The active ingredient in Roundup, glyphosate, has been at the center of controversy due to allegations linking it to cancer. These legal defeats not only pose a significant financial threat to Bayer but also raise concerns about the safety of one of the world's most popular herbicides.

Read More
November 18, 2023
Symptoms and Causes of Non-Hodgkin’s Lymphoma

We’ll explore the symptoms and causes of Non-Hodgkin’s lymphoma, as well as what you can do next if you think you may have developed the condition as a result of exposure to certain chemicals.

Read More
November 11, 2023
What’s the Difference Between Herbicides and Pesticides?

Here, we’ll take a look at exactly what you need to know in order to differentiate between herbicides and pesticides: it’s not always as simple as you’d think.

Read More

About us

We are here to help you and loved ones advocate for justice. Feel free to send us any questions you might have, either about an injury or the process for pursuing justice so we can help you exercise your rights.

Social Media

Stay updated!
Join us to learn more

Facebook IconYouTube IconTwitter Icon

© Copyright Jazz Media Ltd. 2024. All rights reserved

About us

We are here to help you and loved ones advocate for justice. Feel free to send us any questions you might have, either about an injury or the process for pursuing justice so we can help you exercise your rights.

Facebook IconYouTube IconTwitter Icon

© Copyright Jazz Media Ltd. 2020. All rights reserved

crossmenuchevron-down